Canada Bans Ipca Imports Based On U.S. FDA Citations

Canada has joined the U.S. in blocking imports of active pharmaceutical ingredients from an Indian plant of Ipca Laboratories. Health Canada ordered the halt based on U.S. FDA citations against the firm for good manufacturing practices violations, including manipulated and falsified data. Health Canada noted that Ipca had not disputed the U.S. action. (Click here for more

)